Vincent C Marconi

Summary

Affiliation: Emory University
Country: USA

Publications

  1. ncbi Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort
    Alan R Lifson
    Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA
    AIDS Res Ther 8:2. 2011
  2. ncbi Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS
    Vincent C Marconi
    Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, United States of America
    PLoS ONE 6:e17956. 2011
  3. ncbi Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study
    Vincent C Marconi
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    AIDS Res Ther 7:14. 2010
  4. ncbi Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study
    Jason F Okulicz
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
    J Infect Dis 200:1714-23. 2009
  5. ncbi Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care
    Amy C Weintrob
    Infectious Disease Clinical Research Program of the Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    J Acquir Immune Defic Syndr 52:574-80. 2009
  6. ncbi The effect of human immunodeficiency virus on hepatitis B virus serologic status in co-infected adults
    Michael L Landrum
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
    PLoS ONE 5:e8687. 2010
  7. ncbi CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy
    Jason F Okulicz
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, National Naval Medical Center, Bethesda, Maryland, USA
    Clin Infect Dis 50:1187-91. 2010
  8. ncbi Anal cancers among HIV-infected persons: HAART is not slowing rising incidence
    Nancy F Crum-Cianflone
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20892, USA
    AIDS 24:535-43. 2010
  9. ncbi Spontaneous virologic suppression in HIV controllers is independent of delayed-type hypersensitivity test responsiveness
    Jason F Okulicz
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    AIDS Res Ther 9:10. 2012
  10. ncbi Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART
    Amy C Weintrob
    Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    J Acquir Immune Defic Syndr 49:40-7. 2008

Detail Information

Publications11

  1. ncbi Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort
    Alan R Lifson
    Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA
    AIDS Res Ther 8:2. 2011
    ..abstract:..
  2. ncbi Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS
    Vincent C Marconi
    Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, United States of America
    PLoS ONE 6:e17956. 2011
    ..The impact of viral load (VL) decay and cumulative VL on CD4 recovery and AIDS after highly-active antiretroviral therapy (HAART) is unknown...
  3. ncbi Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study
    Vincent C Marconi
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    AIDS Res Ther 7:14. 2010
    ..abstract:..
  4. ncbi Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study
    Jason F Okulicz
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
    J Infect Dis 200:1714-23. 2009
    ..042). Definitions of controllers and LTNPs describe distinct populations whose differing clinical outcomes improve with the stringency of criteria, underscoring the need for comparability between study populations...
  5. ncbi Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care
    Amy C Weintrob
    Infectious Disease Clinical Research Program of the Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    J Acquir Immune Defic Syndr 52:574-80. 2009
    ..We evaluated virologic response to HAART between ethnicities in a large cohort with fewer confounders...
  6. ncbi The effect of human immunodeficiency virus on hepatitis B virus serologic status in co-infected adults
    Michael L Landrum
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
    PLoS ONE 5:e8687. 2010
    ..Factors associated with serologic hepatitis B virus (HBV) outcomes in HIV-infected individuals remain incompletely understood, yet such knowledge may lead to improvements in the prevention and treatment of chronic HBV infection...
  7. ncbi CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy
    Jason F Okulicz
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, National Naval Medical Center, Bethesda, Maryland, USA
    Clin Infect Dis 50:1187-91. 2010
    ..HIV controllers experienced CD4 cell count reconstitution with HAART regardless of pretherapy viral load, including patients with undetectable viral loads at HAART initiation...
  8. ncbi Anal cancers among HIV-infected persons: HAART is not slowing rising incidence
    Nancy F Crum-Cianflone
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20892, USA
    AIDS 24:535-43. 2010
    ..To evaluate the incidence rates of anal cancer over the HIV epidemic and assess the impact of HAART use on anal cancer events...
  9. ncbi Spontaneous virologic suppression in HIV controllers is independent of delayed-type hypersensitivity test responsiveness
    Jason F Okulicz
    Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    AIDS Res Ther 9:10. 2012
    ..abstract:..
  10. ncbi Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART
    Amy C Weintrob
    Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    J Acquir Immune Defic Syndr 49:40-7. 2008
    ..We examined the effect of age at HIV seroconversion on response to HAART...
  11. ncbi Health care transmission of a newly emergent adenovirus serotype in health care personnel at a military hospital in Texas, 2007
    Fernanda C Lessa
    Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 200:1759-65. 2009
    ..From April through June 2007, 15 trainees at one base were hospitalized for pneumonia due to Ad14. Subsequent reports of febrile respiratory illness among health care personnel suggested nosocomial transmission...